早产儿促甲状腺素延迟升高:多次筛查样本与详细临床特征评估的价值
该回顾性研究纳入2014年1月至2023年12月在布鲁塞尔自由大学新生儿筛查中心筛查的3578例早产儿(<37周),评估暂时性与永久性先天性甲状腺功能减退症(CH)及促甲状腺素(TSH)延迟升高的发生率。结果显示CH 10例(0.3%),永久性CH发生率为1/1789(0.05%),其中1例表现为TSH延迟升高;暂时性CH发生率高于永久性CH(1/596 vs 1/1789)。
要点
- 早产儿中永久性CH发生率(1/1789)低于暂时性CH(1/596)。
- 永久性CH早产儿中可发生TSH延迟升高,导致首次干血斑筛查假阴性。
- TSH延迟升高在永久性CH早产儿中并非罕见,支持早产儿进行第二次干血斑筛查。
核心结论
- 早产儿中永久性CH似乎比暂时性CH更罕见(1/1789 vs 1/596)。
- 碘暴露或甲状腺超声显示原位腺体且基因检测阴性、母体阻断抗体阴性时,可怀疑暂时性CH。
- 此类情况下,早期左甲状腺素减停可能有助于避免过度治疗。
- 导致首次干血斑假阴性的TSH延迟升高在永久性CH早产儿中并非不常见,这支持对早产儿进行第二次干血斑筛查。
- 鉴于本研究的回顾性性质,这些发现应谨慎解读,需要进一步的前瞻性研究来证实这些观察结果。
研究设计与样本
- 回顾性研究,纳入2014年1月至2023年12月在布鲁塞尔自由大学新生儿筛查中心筛查的早产儿(<37周)。
- 共纳入3578例早产儿。
- 同时进行了文献综述,以识别早产儿队列中永久性CH伴TSH延迟升高的病例。
主要发现
- 3578例早产儿中,10例诊断为CH(0.3%)。
- CH病例多数为暂时性(10例中6例暂时性,1例死亡,1例仍在接受左甲状腺素治疗且年龄太小无法尝试减停)。
- 6例在首次干血斑筛查时检出,4例在后续干血斑筛查时检出。
- 仅2例确诊为永久性CH,早产儿中永久性CH发生率为1/1789(0.05%)。
- 2例永久性CH中1例表现为TSH延迟升高;基因检测有助于建立腺体原位永久性CH的诊断。
临床怎么用
- 作者认为,TSH延迟升高导致首次干血斑假阴性在永久性CH早产儿中并非不常见,这支持对早产儿进行第二次干血斑筛查。
- 作者认为,碘暴露或甲状腺超声显示原位腺体且基因检测阴性、母体阻断抗体阴性时,可怀疑暂时性CH;此类情况下早期左甲状腺素减停可能有助于避免过度治疗。
局限性
- 鉴于本研究的回顾性性质,这些发现应谨慎解读。
- 需要进一步的前瞻性研究来证实这些观察结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Newborn screening for congenital hypothyroidism (CH) has been implemented in high-income countries since the 1970s to prevent intellectual disability. A delayed thyrotropin (TSH) rise with a normal TSH on the first dry blood spot (DBS) sample, followed by an abnormal TSH on the subsequent DBS, is sometimes observed in preterm newborns. The incidence of permanent CH and the screening process in preterm newborns remain controversial. Our aim was to evaluate the incidence of transient and permanent CH and delayed TSH rise in preterm newborns. The utility of a multiple screening samples is discussed. Methods: We conducted a retrospective study on preterm newborns (<37 weeks of gestation) screened at the Newborn Screening Center of Université Libre de Bruxelles between January 2014 and December 2023. A literature review was performed to identify cases of permanent CH with delayed TSH rise in cohorts of preterm newborns. Results: Of the 3578 preterm newborns included in the study, 10 were diagnosed with CH (0.3%). The majority of CH cases were transient (6 out of 10 transient, one deceased and one under ongoing L-thyroxine, too young for weaning attempt). Six cases were detected at the first DBS, four at subsequent DBS. Only two cases were confirmed as permanent CH, yielding an incidence of 1 in 1789 for permanent CH in preterms (0.05%). One of the two had a delayed TSH rise. Genetic testing helped in establishing the diagnosis of permanent CH with gland in situ. Conclusions: Permanent CH appears to be rarer than transient CH among preterm newborns (1/1789 vs. 1/596). Transient CH may be suspected in case of iodine exposure or thyroid ultrasound showing an in situ gland with negative genetic testing and absent maternal blocking antibodies. In such cases, early L-thyroxine weaning may help avoid overtreatment. A delayed TSH rise leading to a false negative first DBS is not uncommon in preterm newborns with permanent CH. This justifies a second DBS in preterms. Given the retrospective nature of this study, these findings should be interpreted with caution, and further prospective research is warranted to confirm these observations.
引用
- Boros E, Marcelis L, Heinrichs C, et al. Delayed Thyrotropin Rise in Preterm Newborns: Value of Multiple Screening Samples and of a Detailed Clinical Characterization. Thyroid. 2025. PMID: 40498627. doi:10.1089/thy.2025.0051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。